| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5872328 | Clinical Nutrition | 2013 | 10 Pages |
Abstract
The use of EGCG could enhance the effect of conventional cancer therapies through additive or synergistic effects as well as through amelioration of deleterious side effects. Further research, especially at the clinical level, is needed to ascertain the potential role of EGCG as adjuvant in cancer therapy.
Keywords
HNEHBMEC5-FUDOXDaunorubicinolEpigallocatechin-3-gallateTSAHRPCATOEGCGDNRROSarsenic trioxideSide effectsAdjuvantinterleukinionizing radiationTrichostatin ADaunorubicinDoxorubicinCancer therapyHormone refractory prostate cancerHuman brain microvascular endothelial cellscisplatin5-fluorouracilhydroxynonenalGreen teaReactive oxygen species
Related Topics
Health Sciences
Medicine and Dentistry
Critical Care and Intensive Care Medicine
Authors
Elena Lecumberri, Yves Marc Dupertuis, Raymond Miralbell, Claude Pichard,